Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study

Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study

Bone-modifying agents (BMA) such as bisphosphonates and denosumab are frequently used for the treatment of bone metastases, osteoporosis, and multiple myeloma. BMA may lead to anti-resorptive agent-related osteonecrosis of the jaw (ARONJ). This study aimed to clarify the risk factors for and probabi...

Full description

Bibliographic Details
Main Authors: Rieko Shimizu, Shintaro Sukegawa, Yuka Sukegawa, Kazuaki Hasegawa, Sawako Ono, Tomoya Nakamura, Ai Fujimura, Ayaka Fujisawa, Keisuke Nakano, Kiyofumi Takabatake, Hotaka Kawai, Hitoshi Nagatsuka, Yoshihiko Furuki
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Healthcare
Subjects:
anti-resorptive agent-related osteonecrosis of the jaw
bisphosphonate
denosumab
retrospective study
risk factor
tooth extraction
Online Access:https://www.mdpi.com/2227-9032/10/7/1332

Internet

https://www.mdpi.com/2227-9032/10/7/1332

Similar Items